Literature DB >> 22433787

The characteristics of remnant lipoproteins in the fasting and postprandial plasma.

Katsuyuki Nakajima1, Takamitsu Nakano, Yoshiharu Tokita, Takeaki Nagamine, Shin-ichi Yatsuzuka, Younosuke Shimomura, Akira Tanaka, Hiroyuki Sumino, Makoto Nara, Tetsuo Machida, Masami Murakami.   

Abstract

BACKGROUND: Remnant-like lipoprotein particles (RLP) have been measured by cholesterol as RLP-C for CHD risk assessment in the fasting plasma. However, RLP-triglyceride (TG) is a better marker of the characteristics of remnant lipoproteins in the postprandial plasma, especially in plasma with TG concentrations <150 mg/dl.
METHOD: The RLP-TG and RLP-C concentrations in subjects undergoing a health check-up and in volunteers receiving an oral fat load were determined in the fasting and postprandial plasma. TC, TG, HDL-C, LDL-C, apoB 100, apoB48, RLP apoB-100 and RLP apoB48 were also determined.
RESULTS: When fasting TG concentrations were <150 mg/dl, the 95th percentile of RLP-TG was 20mg/dl and the RLP-C 7.5 mg/dl in healthy subjects. The prevalence of RLP-TG and RLP-C above the cut-off values with a TG concentration <150 mg/dl was significantly higher in the metabolic syndrome cases than in the controls. RLP-TG increased significantly in plasma to >20mg/dl after an oral fat load in cases with TG concentrations >80 mg/dl. Further, RLP apoB100, but not RLP apoB48 was highly correlated with the increase of TG in the postprandial plasma.
CONCLUSION: RLP-TG and RLP-C were increased significantly above the cut-off values in the postprandial plasma in healthy volunteers from a TG concentration >80 mg/dl. RLP apoB100, but not RLP apoB48, increased significantly when the plasma TG increased after an oral fat load despite the increase of plasma apoB48. The results show that the major lipoproteins which were increased in postprandial plasma were VLDL remnants, not CM remnants.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22433787     DOI: 10.1016/j.cca.2012.02.026

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Serum TG-lowering properties of plant sterols and stanols are associated with decreased hepatic VLDL secretion.

Authors:  Marleen Schonewille; Gemma Brufau; Ronit Shiri-Sverdlov; Albert K Groen; Jogchum Plat
Journal:  J Lipid Res       Date:  2014-10-27       Impact factor: 5.922

2.  Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.

Authors:  Zareen M Farukhi; Olga V Demler; Michael P Caulfield; Krishnaji Kulkarni; Jay Wohlgemuth; Michael Cobble; Heike Luttmann-Gibson; Chunying Li; John R Nelson; Nancy R Cook; Julie E Buring; Ronald M Krauss; JoAnn E Manson; Samia Mora
Journal:  J Clin Lipidol       Date:  2020-02-21       Impact factor: 4.766

3.  Effects of Moderate Chronic Food Restriction on the Development of Postprandial Dyslipidemia with Ageing.

Authors:  Alejandro Fernández; Lorena Mazuecos; Cristina Pintado; Blanca Rubio; Virginia López; Alain J de Solís; María Rodríguez; Antonio Andrés; Nilda Gallardo
Journal:  Nutrients       Date:  2019-08-10       Impact factor: 5.717

4.  Associations Between Bioavailable Vitamin D and Remnant Cholesterol in Patients With Type 2 Diabetes Mellitus.

Authors:  Gulsum Feyza Turkes; Sezer Uysal; Tevfik Demir; Yucel Demiral; Baris Onder Pamuk; Husnu Yılmaz; Leyla Demir; Mehmet Doruk; Giray Bozkaya
Journal:  Cureus       Date:  2021-02-09

Review 5.  Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease.

Authors:  Chris J Packard
Journal:  Curr Atheroscler Rep       Date:  2022-02-17       Impact factor: 5.113

6.  Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.

Authors:  Henry N Ginsberg; Chris J Packard; M John Chapman; Jan Borén; Carlos A Aguilar-Salinas; Maurizio Averna; Brian A Ference; Daniel Gaudet; Robert A Hegele; Sander Kersten; Gary F Lewis; Alice H Lichtenstein; Philippe Moulin; Børge G Nordestgaard; Alan T Remaley; Bart Staels; Erik S G Stroes; Marja-Riitta Taskinen; Lale S Tokgözoğlu; Anne Tybjaerg-Hansen; Jane K Stock; Alberico L Catapano
Journal:  Eur Heart J       Date:  2021-12-14       Impact factor: 29.983

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.